This study was financially supported by the National Key Research and Development Program of China(No.2016YFC1100701);the National Natural Science Foundation of China(Nos.52022095,51973216,and 51873207);the Science and Technology Development Program of jilin Province(No.20200404182YY);the Youth Innovation Promotion Association of Chinese Academy of Sciences(No.2019005)。
Multidrug-resistance(MDR)featuring complicated and poorly defined mechanisms is a major obstacle to the success of cancer chemotherapy in the clinic.Compound nanoparticles comprising multiple cytostatics with differen...
Osteosarcoma is the most common malignancy in the bone. Current chemotherapy offers limited efficacy with significant side effects, especially for advanced and relapsed osteosarcomas. Nanoparticle-formulated chemother...